SPCC24B10.03 Antibody

What is the SPCC24B10.03 Antibody and what are its primary research applications?

SPCC24B10.03 Antibody (CSB-PA885857XA01SXV) is a polyclonal antibody developed against a recombinant protein from Schizosaccharomyces pombe (strain 972/ATCC 24843), commonly known as fission yeast. This antibody targets the protein encoded by the SPCC24B10.03 gene (UniProt: Q9P7K2) .

Primary applications include:

• Western Blotting (WB)

• Enzyme-Linked Immunosorbent Assay (ELISA)

The antibody is derived from rabbit hosts and specifically reacts with yeast species, making it valuable for researchers working with fission yeast models . Each antibody package typically includes:

For optimal experimental design, researchers should use the provided controls to establish baseline readings and signal-to-noise ratios before proceeding with target sample analysis .

How should I store and handle the SPCC24B10.03 Antibody to maintain its effectiveness?

The SPCC24B10.03 Antibody requires specific storage conditions to maintain its effectiveness:

• Storage temperature: Store at -20°C or -80°C for long-term preservation .

• Aliquoting protocol: To avoid repeated freeze-thaw cycles that degrade antibody quality, divide the stock solution into small single-use aliquots (typically 10μL) upon receipt.

• Working dilution handling: Once diluted for an experiment, store working solutions at 4°C for up to one week; re-freezing diluted antibody is not recommended.

• Expiration considerations: While the manufacturer may provide an expiration date, antibody functionality should be empirically validated periodically, especially for critical experiments.

For Western blot applications, antibody effectiveness can be maintained by:

• Adding 0.02% sodium azide to diluted antibody solutions for extended storage

• Avoiding contamination by using clean pipette tips

• Monitoring for signs of microbial growth or precipitation

These handling practices align with best practices for antibody research and maximize reproducibility across experiments .

What is the recommended protocol for optimizing SPCC24B10.03 Antibody concentration in Western blot experiments?

Optimizing SPCC24B10.03 Antibody concentrations for Western blot requires a systematic approach to balance sensitivity and specificity:

• Initial titration experiment:

  • Prepare serial dilutions of the antibody (1:500, 1:1000, 1:2000, 1:5000)

  • Use identical protein samples across all dilutions

  • Process all blots simultaneously under identical conditions

• Signal-to-noise evaluation:

  • Quantify both specific (target band) and non-specific (background) signals

  • Calculate signal-to-noise ratio for each dilution

  • Select the concentration that maximizes target specificity while minimizing background

• Validation with controls:

  • Positive control: Use the provided 200μg antigen preparation

  • Negative control: Process samples with pre-immune serum at equivalent dilution

  • Specificity control: If available, use knockout/knockdown samples

• Optimization matrix:

Remember that antibody performance depends on the expression level of your target protein in the sample. S. pombe proteins may require optimization specific to yeast cell lysis and protein extraction methods .

How can I validate the specificity of SPCC24B10.03 Antibody for my particular experiment?

Validating SPCC24B10.03 Antibody specificity requires implementing multiple complementary approaches as recommended by the International Working Group for Antibody Validation:

• Genetic strategy (Gold standard):

  • Generate SPCC24B10.03 gene knockout strains in S. pombe

  • Process wild-type and knockout samples in parallel

  • Absence of signal in knockout samples confirms specificity

  • If knockout is lethal, use regulated promoter systems for conditional expression

• Orthogonal strategy:

  • Compare antibody-based detection with an orthogonal method like mass spectrometry

  • Correlate protein levels detected by both methods across multiple samples

  • Strong correlation supports antibody specificity

• Multiple antibody strategy:

  • Test different antibodies (if available) targeting distinct epitopes of SPCC24B10.03

  • Compare localization or expression patterns

  • Concordant results increase confidence in specificity

• Recombinant expression strategy:

  • Overexpress tagged SPCC24B10.03 in yeast cells

  • Confirm co-localization or co-detection of tag and antibody signal

  • This validates antibody detection of the overexpressed protein

• Immunoprecipitation-Mass Spectrometry:

  • Use the antibody to immunoprecipitate proteins from yeast lysate

  • Analyze precipitate by mass spectrometry

  • SPCC24B10.03 should be among the top proteins identified

Remember to document all validation experiments thoroughly, as this will strengthen the reliability of subsequent research findings and address reproducibility concerns .

How can I determine the epitope specificity of the SPCC24B10.03 Antibody?

Determining epitope specificity of the SPCC24B10.03 polyclonal antibody involves several advanced approaches:

• Peptide array analysis:

  • Generate overlapping peptides (15-20 amino acids) spanning the entire SPCC24B10.03 protein sequence

  • Spot peptides onto membranes in an array format

  • Probe with the antibody and detect binding signals

  • Identify peptide sequences that show strong reactivity

• Competitive binding assays:

  • Pre-incubate antibody with increasing concentrations of synthesized peptides

  • Measure remaining antibody activity against full-length protein

  • Peptides containing the epitope will inhibit antibody binding in a dose-dependent manner

• Structural epitope mapping:

  • If 3D structure of SPCC24B10.03 is available, perform alanine scanning mutagenesis

  • Generate variants with point mutations in surface-exposed residues

  • Test antibody binding to each variant

  • Residues critical for binding represent the epitope

• Hydrogen-deuterium exchange mass spectrometry:

  • Compare hydrogen-deuterium exchange rates of SPCC24B10.03 protein alone versus antibody-bound

  • Regions protected from exchange when antibody is bound represent the epitope

• Computational epitope prediction:

  • Use tools like RosettaAntibodyDesign to predict likely binding interfaces

  • Combine with experimental validation to narrow epitope candidates

Understanding epitope specificity enables advanced applications such as:

• Designing blocking peptides for competition assays

• Assessing potential cross-reactivity with homologous proteins

• Rational optimization of antibody affinity through targeted mutations

What are the best approaches for using SPCC24B10.03 Antibody in co-immunoprecipitation experiments with S. pombe proteins?

Co-immunoprecipitation (Co-IP) with SPCC24B10.03 Antibody requires specialized protocols for S. pombe proteins:

• Cell lysis optimization:

  • Use enzymatic digestion with zymolyase to disrupt the rigid yeast cell wall

  • Employ gentle lysis buffers (e.g., 50mM Tris-HCl pH 7.5, 150mM NaCl, 0.5% NP-40) with protease inhibitors

  • Maintain low temperatures throughout to prevent protein degradation

  • Consider crosslinking with formaldehyde (0.5-1%) for transient interactions

• Pre-clearing strategy:

  • Incubate lysate with protein A/G beads and pre-immune serum

  • Remove non-specific binding proteins before adding SPCC24B10.03 Antibody

  • This reduces background and increases specificity

• Antibody coupling options:

  • Direct method: Add antibody to pre-cleared lysate, then capture with beads

  • Pre-coupling method: Bind antibody to beads first, then incubate with lysate

  • Pre-coupling often yields cleaner results with fewer contaminating antibody bands

• Controls hierarchy:

  • Input control: 5-10% of starting lysate

  • No-antibody control: Beads only

  • Pre-immune serum control: Non-specific antibody binding

  • Tag-based validation: If possible, perform parallel IP with epitope-tagged version

• Elution and validation considerations:

  • Low pH elution may preserve protein-protein interactions better than boiling in SDS

  • Validate pulled-down complexes by mass spectrometry

  • Confirm interactions through reciprocal Co-IP when possible

For analyzing S. pombe protein complexes effectively, optimize buffer ionic strength (150-300mM NaCl) and detergent concentration through pilot experiments to balance solubilization and preservation of protein-protein interactions .

How should I address high background issues when using SPCC24B10.03 Antibody in Western blots?

High background when using SPCC24B10.03 Antibody can significantly impair data interpretation. Address this systematically:

• Blocking optimization:

  • Test multiple blocking agents (5% BSA, 5% milk, commercial blockers)

  • Extend blocking time (1-2 hours at room temperature or overnight at 4°C)

  • BSA often performs better than milk for phospho-specific antibodies

• Washing protocol enhancement:

  • Increase wash buffer stringency (add 0.1-0.3% Tween-20 or 0.05-0.1% SDS)

  • Extend washing duration (5 washes × 10 minutes each)

  • Use larger volumes of wash buffer (≥10× membrane volume)

• Antibody dilution adjustment:

  • Further dilute primary antibody (try 2-5× more dilute than current)

  • Reduce incubation temperature (4°C instead of room temperature)

  • Add 0.05% sodium azide to prevent microbial growth during long incubations

• Sample preparation refinement:

  • Improve yeast cell lysis procedure (use glass bead disruption for complete lysis)

  • Include additional protease inhibitors to prevent degradation

  • Remove cell wall debris completely by centrifugation (14,000 × g for 15 minutes)

• Systematic improvement matrix:

If background issues persist, consider using an alternative detection system (e.g., fluorescent secondary antibodies) which often provides better signal-to-noise ratio than chemiluminescence for challenging antibodies .

What are the key considerations for quantitative analysis of Western blots using SPCC24B10.03 Antibody?

Quantitative Western blot analysis with SPCC24B10.03 Antibody requires rigorous control of variables affecting signal intensity:

• Linear dynamic range determination:

  • Create a standard curve using serial dilutions of your protein sample

  • Plot signal intensity versus protein amount

  • Identify the linear range where signal correlates proportionally with protein quantity

  • Design experiments to operate within this linear range

• Normalization strategy selection:

  • Load verification: Total protein staining (Ponceau S, SYPRO Ruby, Coomassie)

  • Housekeeping proteins: Carefully select yeast-appropriate reference proteins

  • For S. pombe, consider Act1 (actin) or Cdc2 (cell division control protein 2)

  • Validate that normalization proteins remain constant under your experimental conditions

• Technical replication approach:

  • Run at least three biological replicates

  • Include technical replicates on separate blots

  • Calculate both intra-assay and inter-assay coefficients of variation

  • Acceptable CV values should be <15% for intra-assay and <20% for inter-assay variability

• Densitometry best practices:

  • Use local background subtraction for each lane

  • Define analysis boundaries consistently across all samples

  • Avoid saturated pixels which compress dynamic range

  • Extract raw intensity values rather than processed images

• Statistical analysis guidance:

  • Test for normal distribution before applying parametric tests

  • Use appropriate statistical tests (t-test, ANOVA) with corrections for multiple comparisons

  • Report confidence intervals alongside p-values

  • Consider biological significance beyond statistical significance

For time-course experiments or comparative studies, prepare all samples simultaneously and process on the same blot when possible. If multiple blots are required, include identical reference samples on each blot to allow inter-blot normalization .

How can I modify SPCC24B10.03 Antibody for specialized applications like immunofluorescence microscopy in fission yeast?

Although SPCC24B10.03 Antibody is primarily validated for Western blot and ELISA applications, researchers can adapt it for immunofluorescence microscopy through careful optimization:

• Fixation method optimization:

  • Test multiple fixation protocols:

    • Methanol fixation (-20°C, 6 minutes)

    • Formaldehyde (3.7%, 30 minutes) followed by cell wall digestion

    • Combined formaldehyde-glutaraldehyde for enhanced structure preservation

  • The rigid cell wall of S. pombe requires specialized approaches to maintain morphology while enabling antibody access

• Cell wall permeabilization strategies:

  • Enzymatic digestion with zymolyase (1mg/ml, 30 minutes at 37°C)

  • Combination of mechanical disruption and chemical permeabilization

  • Creation of spheroplasts before fixation for better antibody penetration

• Signal amplification techniques:

  • Tyramide signal amplification (TSA) for low-abundance proteins

  • Two-step secondary antibody systems with biotinylated intermediates

  • Quantum dot conjugation for enhanced photostability and brightness

• Co-localization experimental design:

  • Use orthogonal markers for subcellular compartments

  • Perform sequential immunostaining with antibodies raised in different species

  • Validate localization patterns with fluorescently tagged proteins

• Advanced imaging considerations:

  • Super-resolution techniques (STORM, PALM) require specialized secondary antibodies

  • For live-cell applications, consider antibody fragment generation through enzymatic digestion

  • Implement deconvolution algorithms to enhance signal detection in thick yeast cells

When adapting this antibody for microscopy applications, extensive controls including peptide competition and genetic knockouts are essential to validate specificity in this different application context .

What approaches should I consider for integrating computational antibody design with experimental validation of SPCC24B10.03 Antibody?

Integrating computational approaches with experimental validation of SPCC24B10.03 Antibody represents a cutting-edge research direction:

• Epitope prediction and refinement:

  • Apply computational algorithms like RosettaAntibodyDesign (RAbD) to predict antibody-antigen binding interfaces

  • Identify potential conformational epitopes that may not be detected by linear peptide mapping

  • Use molecular dynamics simulations to assess epitope accessibility in native protein conformations

• Affinity maturation strategies:

  • Implement in silico affinity maturation protocols to design improved variants

  • Create virtual libraries of antibody mutants through computational mutagenesis

  • Rank candidates by predicted binding energy improvements

  • Experimentally validate top candidates through directed mutagenesis

• Structure-guided antibody engineering workflow:

  • Computationally model the SPCC24B10.03 protein structure if not available

  • Dock existing antibody to predicted structure

  • Optimize complementarity-determining regions (CDRs) in silico

  • Express and test modified antibodies experimentally

• Integration of experimental feedback:

  • Use experimental binding data to refine computational models

  • Implement machine learning approaches trained on experimental results

  • Create iterative design-build-test cycles for continuous improvement

• Application-specific optimization pipeline:

This integrated approach combines the strengths of computational prediction with rigorous experimental validation, accelerating the development of improved antibody variants for challenging applications .

What information should I include when reporting results obtained using SPCC24B10.03 Antibody in scientific publications?

Comprehensive reporting of antibody usage is critical for reproducibility. When publishing results with SPCC24B10.03 Antibody, include:

Following these guidelines aligns with best practices recommended by the International Working Group for Antibody Validation and enhances research reproducibility across laboratories .

How can I contribute to improving the reproducibility of research using SPCC24B10.03 Antibody?

Contributing to improved reproducibility with SPCC24B10.03 Antibody extends beyond your immediate research:

• Community validation initiatives:

  • Share validation data through antibody validation repositories

  • Submit detailed protocols to community resources

  • Participate in multi-laboratory validation studies

  • Report both positive and negative validation results

• Methodological transparency enhancement:

  • Maintain detailed electronic laboratory notebooks

  • Document all experimental variables including lot numbers

  • Share raw data alongside published findings

  • Create comprehensive method sections that enable precise replication

• Comparative antibody assessment:

  • Test multiple antibodies targeting the same protein when possible

  • Document performance differences between antibody sources

  • Create reference datasets for antibody benchmarking

  • Validate across multiple experimental conditions

• Long-term antibody characterization:

  • Monitor antibody performance over time and multiple lots

  • Document any drift in specificity or sensitivity

  • Establish institutional repositories of validated antibodies

  • Create "antibody passports" with complete validation histories

• Education and training contributions:

  • Develop training materials for proper antibody validation

  • Mentor students in rigorous antibody validation methods

  • Advocate for validation standards in your institution

  • Participate in peer review focused on antibody methodology

By implementing these practices, researchers collectively strengthen the reliability of antibody-based methods and accelerate scientific progress through increased reproducibility. The "antibody characterization crisis" highlighted in several publications can only be addressed through community-wide efforts and individual commitment to rigorous methodologies .